Memphasys Ltd has released a press release.
Felix Clinical Trial complete, Data Lock expected in 2 weeks
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from Memphasys
- Publication Highlights Diagnostic Potential of RoXsta TM
- Heranova Felix System Utilisation Testing commences in China
- Bovine Study commences to assess RoXsta antioxidant system
- Felix Clinical Registration Study completed, expanding mkt
- Letter of Intent with Heranova for Felix System Distribution
Later from Memphasys
- Leading Brazilian Andrology Clinic to test Felix System
- Felix Data lock complete and regulatory submission commenced
- Extension of Convertible Notes
- Half Yearly Report and Accounts
- Felix Trial Confirms Best-in-Class Performance
Follow Memphasys into a list and get an email when it puts out news.
Follow Memphasys